Endofert-H 28 Tablets

babies: not applicable. lactating mothers: it is unsafe to use in lactating mothers.
studies have shown evidence of medicine in breast milk. it may cause toxicity to the baby.
pregnancy: it is unsafe to use in pregnancy. seek doctor's advice.
driving: endofert-h does not affect the driving ability alcohol: avoid consuming alcohol while taking endofert-h tablets as it causes severe liver damage. kidney: endofert-h tablets should be used in caution with patients suffering from kidney disease.
you may require a dose adjustment and regular monitoring of kidney function. seek the doctor's advice before using the medication.
liver: endofert-h tablet is not recommended in severe liver disease. seek a doctor's advice before using this medication..

melasma breast tenderness abdominal cramping changes in the menstrual periods swelling of extremities vaginal discomfort.

endofert-h is a female sex hormone that plays a vital role in maintaining the reproductive system. it works by replacing the estrogen that your body produces typically and thickens the uterus lining to allow fertilized eggs for implantation..

if you miss a dose, take it as soon as possible. if it is near the time of the next dose, then skip the missed dose.
take the prescribed dose on your regular time daily. don't double the dose to catch up with the missed dose..

• consume plenty of water and keep yourself well-hydrated while on medication. • although you feel better, do not stop the medication.
continue the course as directed by your doctor. • alcohol consumption needs to be avoided while on this medication, leading to severe liver damage.
• talk to your doctor immediately if you are pregnant while taking endofert-h..

• endofert-h + prednisone: concurrent use leads to an increase in the blood levels of endofert-h • endofert-h + vitamin d3: concurrent use leads to an increase in the endofert-h levels by decreasing the renal clearance of endofert-h • endofert-h + tofacitinib: concurrent use leads to nephrotoxicity and ototoxicity • endofert-h + raloxifene: concurrent use leads to an increase in the endofert-h levels by decreasing the renal clearance of endofert-h.